ZIOPHARM Oncology, Inc (ZIOP) Covered Calls

ZIOPHARM Oncology, Inc covered calls ZIOPHARM Oncology, Inc. is a biopharmaceutical Company that is seeking to develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs that address unmet medical needs.

You can sell covered calls on ZIOPHARM Oncology, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ZIOP (prices last updated Fri 4:16 PM ET):

ZIOPHARM Oncology, Inc (ZIOP) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.48 -0.17 5.46 5.90 1.0M 5.4 0.9B
Covered Calls For ZIOPHARM Oncology, Inc (ZIOP)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 5 0.65 5.25 -4.8% -60.4%
Oct 18 5.5 0.75 5.15 6.8% 27.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company currently in developmental stage that seeks to acquire, develop and commercialize, on its own or with commercial partners, a diverse portfolio of cancer therapies. The company also has a portfolio of small molecule drug candidates, which are no longer a strategic focus of its development activities for which the company is seeking partners to pursue further development and commercialization. It is currently focused on two clinical stage product candidates: Ad-RTS-IL-12 + veledimex and DC-RTS-IL-12 + veledimex. Ziopharm Oncology was founded on September 9, 2003 and is headquartered in Boston, MA.